Swati Gupta
Swati Gupta is the head of emerging infectious diseases at IAVI, a non-profit scientific research organization. She gained recognition for her role in the rapid development of mRNA vaccines during the COVID-19 pandemic, which was made possible through unprecedented global collaboration among various sectors, including government, industry, and academia. Gupta's work underscores the critical need for coordinated efforts in scientific research to tackle complex health challenges effectively.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Argentina | 1 | 8.00 | 0.04% | +0% | 45,195,774 | 18,839 | $450,000 | 188$ |
| Liechtenstein | 1 | 7.00 | 0.04% | +0% | 38,137 | 14 | $6,900 | 3$ |
| Australia | 1 | 9.00 | 0.06% | +0% | 25,499,884 | 14,731 | $1,380,000 | 797$ |
| Totals | 3 | 70,733,795 | 33,584 | $1,836,900 | 988$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Argentina:
Swati Gupta discusses the unprecedented global collaboration that led to the rapid development of COVID-19 vaccines.
8
Liechtenstein:
Swati Gupta discusses the unprecedented global collaboration that led to the rapid development of mRNA vaccines.
7
Australia:
Swati Gupta explained the unprecedented global collaboration that led to the rapid development of mRNA vaccines for COVID-19.
9